Clinical Trials Logo

Filter by:
NCT ID: NCT03288584 Recruiting - Clinical trials for Rheumatoid Arthritis

Effects of Interleukin-6 Inhibition on Vascular, Endothelial and Left Ventricular Function in Rheumatoid Arthritis

Start date: October 27, 2017
Phase:
Study type: Observational

Recent studies show beneficial effect of the inhibition of interleukin-6 (IL-6) activity on vascular and left ventricular (LV) function. The purpose of this study is to investigate whether anakinra, an IL-6 receptor antagonist, improves vascular, endothelial and LV function in patients with rheumatoid arthritis (RA).

NCT ID: NCT03251469 Recruiting - Hip Fractures Clinical Trials

Single Dose of Tranexamic Acid and Blood Loss, in Elderly Patients With Hip Fracture

Start date: January 2013
Phase: Phase 2
Study type: Interventional

The aim of this study is to investigate the hypothesis that single dose of tranexamic acid (TXA) preoperatively will lower blood loss and transfusion rate in elderly patients with hip fractures (intertrochanteric or Subcapital), that will be treated with intramedullary nailing and cemented hemiarthroplasty respectively. After application of inclusion and exclusion criteria, patients will be randomized in two groups. Group 1 will include patients that receive preoperatively single dose of TXA (15mg/kg) and Group 2 will include patients that receive normal saline (control group).

NCT ID: NCT03248076 Recruiting - Opioid Use Clinical Trials

Effect of Fentanyl on Main Opioid Receptor (OPRM1) on Human Granulosa Cells.

Start date: April 1, 2017
Phase: N/A
Study type: Observational

Opioids is known that produce not only analgesia but also hyperalgesia through activation of central glutaminergic system-GABA. At the same time, recently it was found that the main opioid receptor (OPRM1) is present on human granulosa cells and exogenous opiates and their antagonists can influence granulosa cell vascular endothelial growth factor (VEGF) production via OPRM1, causing ovarian hyperstimulation syndrome. This study aims to investigate if a single exposure to opioids is enough to produce activation of stress mechanism during oocyte retrieval.

NCT ID: NCT03241394 Recruiting - Obesity Clinical Trials

The Monocyte Subsets in Obese Patients With and Without Metabolic Syndrome

Start date: July 25, 2017
Phase: N/A
Study type: Observational

Obesity is associated with a chronic low-grade inflammation characterized by macrophage infiltration in adipose tissue that induces insulin resistance and the appearance of metabolic syndrome (MS). The aim of the study was the investigation of whether circulating monocyte subsets are differentially regulated in MS.

NCT ID: NCT03240159 Recruiting - Pregnancy, Ovarian Clinical Trials

Long Antagonist Protocol for IVF With Single Luteal Dose of Degarelix

Start date: February 15, 2017
Phase: Phase 3
Study type: Interventional

A prospective study of three different doses of Degarelix in late luteal phase of women undergoing ovarian stimulation for IVF

NCT ID: NCT03222895 Recruiting - Clinical trials for Esophageal Neoplasms

Distribution of Lymph Node Metastases in Esophageal Carcinoma

TIGER
Start date: March 1, 2019
Phase:
Study type: Observational [Patient Registry]

Background: Lymph node status is an important prognostic parameter in esophageal carcinoma and an independent predictor of survival. Distribution of metastatic lymph nodes may vary with tumor location, tumor histology, tumor invasion depth and neoadjuvant therapy. Surgical strategy depends on the distribution pattern of nodal metastases but consensus on the extent of lymphadenectomy differs worldwide. Especially for adenocarcinoma the distribution of lymph node metastases has not yet been described in large series. Aim of the present study is to evaluate the distribution of lymph node metastases in esophageal carcinoma specimens following transthoracic esophagectomy with at least a 2-field lymphadenectomy. Methods: The TIGER-study is a multinational observational cohort study. All patients with a resectable esophageal or gastro-esophageal junction carcinoma in whom a transthoracic esophagectomy with a 2- or 3-field lymphadenectomy is performed in participating centers will be included. All lymph node stations will be excised and separately sent for pathological examination. Cluster analysis will be performed to identify patterns of metastases in relation to tumor location, tumor histology, tumor invasion depth and neoadjuvant therapy. Conclusion: TIGER will provide a roadmap of the location of lymph node metastases in relation to tumor histology, tumor location, invasion depth, number of lymph nodes and lymph node metastases, pre-operative diagnostics, neo-adjuvant therapy and survival. Patient-tailored treatment can be developed on the basis of these results, such as the the optimal radiation field and extent of lymphadenectomy based on the primary tumor characteristics.

NCT ID: NCT03218488 Recruiting - Psoriasis Clinical Trials

A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque Psoriasis

STELARA
Start date: August 29, 2017
Phase:
Study type: Observational

The purpose of this study is to monitor the long-term safety of ustekinumab in pediatric participants (6 years to 17 years of age at the time of inclusion) with moderate to severe plaque psoriasis, through monitoring for the following adverse events potentially related to immune modulation: serious infections, malignancies and autoimmunity; and to monitor the long-term effects of ustekinumab on growth (weight, height, body mass index) and development (sexual maturity based on the Tanner Scale).

NCT ID: NCT03195543 Recruiting - Clinical trials for Chronic Thromboembolic Pulmonary Hypertension

Assessment of Blood Coagulation Disorders in Patients With Pulmonary Hypertension

Start date: March 12, 2015
Phase:
Study type: Observational

The objective of the present study is to assess blood coagulation disorders in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension. The investigators aim to evaluate any possible coagulation abnormalities related to the patients' primary disease and any possible effects the pulmonary hypertension- specific therapy may have on hemostasis.

NCT ID: NCT03150680 Recruiting - Clinical trials for Coronary Artery Disease

Development of a Risk Prediction Algorithm Through the Investigation of Genetic Risk Factors and the Complexity of Coronary Artery Disease to Estimate Future Risk of Cardiovascular Events: Angiographic (SYNTAX Score), Clinical and Pharmacogenetic Analysis.

GESS
Start date: September 1, 2017
Phase: N/A
Study type: Observational [Patient Registry]

The purpose of the research project is to investigate the potential association of 207 genetic polymorphisms with the complexity and the severity of coronary artery disease (SYNTAX score), along with the patients' response to clopidogrel and statin therapy. The aim of the study is to combine genetic, pharmacogenetic, clinical and laboratory data in order to create an algorithm (GEnetic Syntax Score-GESS) that will enable an individualized therapeutic patient approach.

NCT ID: NCT03142152 Recruiting - Heart Failure Clinical Trials

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

The objective of this prospective, randomized, blinded clinical trial is to assess the safety and efficacy of the Carillon Mitral Contour System in treating heart failure with functional regurgitation (FMR).